X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Fact Check: How hospitals continue to drive health care spending

By Nicole Longo  |    August 21, 2019
There is a lot of talk about health care costs in the United States that is mostly centered on prescription medicine spending, overlooking the largest share of U.S. health care spending – hospital...   Read More

Three things to know about the Part D GAO report

By Nicole Longo  |    August 16, 2019
The Government Accountability Office (GAO) recently released a new report looking at Medicare Part D and the role of Pharmacy Benefit Managers (PBMs) in the program. While the report provides a...   Read More

Four states adopt first-in-the-nation laws to protect patients from surprise insurer practices

By Nick McGee  |    July 15, 2019
West Virginia, Virginia, Arizona and Illinois recently became the first states in America to adopt patient-centered legislation to bring relief and more predictability to patients facing high...   Read More

New Let’s Talk About Cost TV ad asks: Why aren’t patients sharing in savings at the pharmacy counter?

By Priscilla VanderVeer  |    July 9, 2019
For the last two years, our Let’s Talk About Cost campaign has sought to answer questions people have about their medicine costs and advance a dialogue on how we can make medicines more affordable...   Read More

Study finds hospitals continue to mark up medicines up to 500% of their cost

By Holly Campbell  |    July 9, 2019
A new analysis from the Moran Company found hospitals continue to charge, on average, five times their cost for medicines, driving up cost sharing and premiums for patients across the country....   Read More

Three reasons why the latest Rx Savings Solutions analysis is misleading

By Holly Campbell  |    July 2, 2019
Yesterday, multiple news outlets featured data from Rx Savings Solutions on medicine price trends. These data reflect list price increases, ignoring the significant rebates and discounts on...   Read More

How the rebate rule would help reduce patients’ out-of-pocket costs

By Tom Wilbur  |    June 3, 2019
The Department of Health and Human Services recently proposed a rule that would encourage using discounts negotiated between biopharmaceutical manufacturers and Part D plans to reduce patients’...   Read More

New study finds hospitals continue to push patients to costlier outpatient settings

By Holly Campbell  |    May 13, 2019
A new study from the Health Care Cost Institute found that, for commercially insured patients, almost 50 percent of medicines administered by physicians, including treatments for diseases like...   Read More

4 Things to know about the IQVIA “Medicine Use and Spending” report

By Holly Campbell  |    May 9, 2019
Today, IQVIA released its Medicine Use and Spending in the U.S. – A Review of 2018 and Outlook to 2023 report – highlighting the drivers behind medicine price and spending trends, patient...   Read More

Six policy solutions to help patients afford their insulin

By Holly Campbell  |    April 9, 2019
Updated on 08/12/2019 Dramatic improvements in how we treat diabetes have transformed the lives of patients, but too many struggle to afford their insulin and other medicines at the pharmacy...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates